BridgeBio Pharma Market Cap 2018-2024 | BBIO

BridgeBio Pharma market cap as of November 10, 2024 is $5.09B.

BridgeBio Pharma market cap history and chart from 2018 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding.

BridgeBio Pharma Market Cap 2018-2024 | BBIO

BridgeBio Pharma market cap history and chart from 2018 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$19.4B
Dr Reddy's Laboratories (RDY)$12.6B
Bausch Health Cos (BHC)$3.4B
Amphastar Pharmaceuticals (AMPH)$2.4B
Supernus Pharmaceuticals (SUPN)$2B
Taysha Gene Therapies (TSHA)$307M
Personalis (PSNL)$241M
Assembly Biosciences (ASMB)$106M
Grace Therapeutics (GRCE)$30M
Sol-Gel Technologies (SLGL)$16M
Evoke Pharma (EVOK)$5M
Teligent (TLGT)$0M